Randy A Jones1, Patricia J Hollen, Jennifer Wenzel, Geoff Weiss, Daniel Song, Terran Sims, Gina Petroni. 1. Author Affiliations: School of Nursing (Drs Jones and Hollen and Ms Sims) and School of Medicine (Dr Weiss), University of Virginia, Charlottesville; School of Nursing (Dr Wenzel) and School of Medicine (Dr Daniel Song), Johns Hopkins University, Baltimore, Maryland; and Public Health Sciences, University of Virginia, Charlottesville (Dr Petroni).
Abstract
BACKGROUND: Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer deaths among men in the United States. Patients with advanced prostate cancer are vulnerable to difficult treatment decisions because of the nature of their disease. OBJECTIVE: The aims of this study were to describe and understand the lived experience of patients with advanced prostate cancer and their decision partners who utilized an interactive decision aid, DecisionKEYS, to make informed, shared treatment decisions. METHODS: This qualitative study uses a phenomenological approach that included a sample of 35 pairs of patients and their decision partners (16 pairs reflected patients with <6 months since their diagnosis of metastatic castration-resistant prostate cancer; 19 pairs reflected patients with >6 months since their diagnosis of metastatic castration-resistant prostate cancer). Qualitative analysis of semistructured interviews was conducted describing the lived experience of patients with advanced prostate cancer and their decision partners using an interactive decision aid. RESULTS: Three major themes emerged: (1) the decision aid facilitated understanding of treatment options; (2) quality of life was more important than quantity of life; and (3) contact with healthcare providers greatly influenced decisions. CONCLUSIONS: Participants believed the decision aid helped them become more aware of their personal values, assisted in their treatment decision making, and facilitated an interactive patient-healthcare provider relationship. IMPLICATIONS FOR PRACTICE: Decision aids assist patients, decision partners, and healthcare providers make satisfying treatment decisions that affect quality/quantity of life. These findings are important for understanding the experiences of patients who have to make difficult decisions.
BACKGROUND:Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer deaths among men in the United States. Patients with advanced prostate cancer are vulnerable to difficult treatment decisions because of the nature of their disease. OBJECTIVE: The aims of this study were to describe and understand the lived experience of patients with advanced prostate cancer and their decision partners who utilized an interactive decision aid, DecisionKEYS, to make informed, shared treatment decisions. METHODS: This qualitative study uses a phenomenological approach that included a sample of 35 pairs of patients and their decision partners (16 pairs reflected patients with <6 months since their diagnosis of metastatic castration-resistant prostate cancer; 19 pairs reflected patients with >6 months since their diagnosis of metastatic castration-resistant prostate cancer). Qualitative analysis of semistructured interviews was conducted describing the lived experience of patients with advanced prostate cancer and their decision partners using an interactive decision aid. RESULTS: Three major themes emerged: (1) the decision aid facilitated understanding of treatment options; (2) quality of life was more important than quantity of life; and (3) contact with healthcare providers greatly influenced decisions. CONCLUSIONS:Participants believed the decision aid helped them become more aware of their personal values, assisted in their treatment decision making, and facilitated an interactive patient-healthcare provider relationship. IMPLICATIONS FOR PRACTICE: Decision aids assist patients, decision partners, and healthcare providers make satisfying treatment decisions that affect quality/quantity of life. These findings are important for understanding the experiences of patients who have to make difficult decisions.
Authors: B A Mahal; M-H Chen; C L Bennett; M W Kattan; O Sartor; K Stein; A V D'Amico; P L Nguyen Journal: Prostate Cancer Prostatic Dis Date: 2014-10-28 Impact factor: 5.554
Authors: Jesse D Sammon; Rana R McKay; Simon P Kim; Akshay Sood; Shyam Sukumar; Matthew H Hayn; Jim C Hu; Adam S Kibel; Paul L Nguyen; James O Peabody; Fred Saad; Maxine Sun; Briony Varda; Mani Menon; Toni K Choueiri; Quoc-Dien Trinh Journal: Urology Date: 2015-02 Impact factor: 2.649
Authors: Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: Charles J Ryan; Matthew R Smith; Johann S de Bono; Arturo Molina; Christopher J Logothetis; Paul de Souza; Karim Fizazi; Paul Mainwaring; Josep M Piulats; Siobhan Ng; Joan Carles; Peter F A Mulders; Ethan Basch; Eric J Small; Fred Saad; Dirk Schrijvers; Hendrik Van Poppel; Som D Mukherjee; Henrik Suttmann; Winald R Gerritsen; Thomas W Flaig; Daniel J George; Evan Y Yu; Eleni Efstathiou; Allan Pantuck; Eric Winquist; Celestia S Higano; Mary-Ellen Taplin; Youn Park; Thian Kheoh; Thomas Griffin; Howard I Scher; Dana E Rathkopf Journal: N Engl J Med Date: 2012-12-10 Impact factor: 91.245
Authors: Karen R Sepucha; Cornelia M Borkhoff; Joanne Lally; Carrie A Levin; Daniel D Matlock; Chirk Jenn Ng; Mary E Ropka; Dawn Stacey; Natalie Joseph-Williams; Celia E Wills; Richard Thomson Journal: BMC Med Inform Decis Mak Date: 2013-11-29 Impact factor: 2.796
Authors: Laura B Oswald; Frank A Schumacher; Brian D Gonzalez; Kelvin A Moses; David F Penson; Alicia K Morgans Journal: Patient Prefer Adherence Date: 2020-10-14 Impact factor: 2.711
Authors: Lourdes R Carhuapoma; Winter M Thayer; Catherine E Elmore; Jane Gildersleeve; Tanmay Singh; Farah Shaukat; Melissa K Uveges; Tamryn Gray; Crystal Chu; Daniel Song; Patricia J Hollen; Jennifer Wenzel; Randy A Jones Journal: Trials Date: 2021-09-16 Impact factor: 2.728
Authors: Martin J Connor; Mesfin G Genie; David Burns; Edward J Bass; Michael Gonzalez; Naveed Sarwar; Alison Falconer; Stephen Mangar; Tim Dudderidge; Vincent Khoo; Mathias Winkler; Hashim U Ahmed; Verity Watson Journal: Eur Urol Open Sci Date: 2021-12-20